Literature DB >> 19877893

Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinoma.

Roberto Manfredi1, Nicola Dentale, Benedetta Piergentili, Cristian Pultrone, Eugenio Brunocilla.   

Abstract

Two (2) exemplary case reports of respiratory granulomatous infection caused by Bacillus of Calmette-Guérin (BCG), in patients who were repeatedly treated with local, intravesical adjuvant BCG therapy for a relapsing transitional bladder carcinoma, are outlined and discussed on the grounds of the cumbersome diagnostic and differential diagnostic process (especially when a prior tuberculosis and a concurrent chronic obstructive pulmonary disease are of concern), along with an updated literature revision. Only 4 cases of respiratory BCG-itis (pulmonary tuberculosis-like forms) have been reported, to date, to the best of our knowledge (2 of them following the bladder instillation of BCG). One (1) episode of ours represents the first described case with a dual, concomitant granulomatous localization of BCG-itis, also involving the genitourinary tract.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877893     DOI: 10.1089/cbr.2009.0668

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  4 in total

1.  BCGitis: A rare complication after intravesical BCG therapy.

Authors:  Maria João Oliveira; Daniel Vaz; Aurora Carvalho; Rosário Braga; Raquel Duarte
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

Review 2.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

3.  BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6.

Authors:  Makoto Tobiume; Tsutomu Shinohara; Takahira Kuno; Shinji Mukai; Keishi Naruse; Nobuo Hatakeyama; Fumitaka Ogushi
Journal:  BMC Pulm Med       Date:  2014-03-05       Impact factor: 3.317

4.  Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer.

Authors:  Tara Rachakonda; Brian Kendall; Adam M Spivak; Jonathan Boltax
Journal:  Open Forum Infect Dis       Date:  2017-06-17       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.